Nutra Pharma Corp. NPHC
0.00 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.005
- YTD
- 0.00%
- 1 year
- 0.00%
News
defenseworld.net Nutra Pharma (OTCMKTS:NPHC) versus XOMA Royalty (NASDAQ:XOMA) Head-To-Head Review XOMA Royalty (NASDAQ: XOMA - Get Free Report) and Nutra Pharma (OTCMKTS:NPHC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two…
watchdoguganda.com REPORT: Buganda, Ankole & Busoga Regions Getting Highest Remittances From Abroad The 2024 National Population & Housing Census (NPHC) shows that out of 10.6 million households in Uganda, 155,200 (about 1.5 percent) received remittances during the last 12 months preceding the NPHC…
watchdoguganda.com Why SPA Mutyabule believes census is a good tool in combating poverty in Busoga THE Senior Presidential Advisor (SPA) on Poverty Alleviation in Busoga, Mrs. Florence Mutyabule has implored the people in the region to wholly embrace the ongoing National Population and Housing…
prismmediawire.com Nutra Pharma Corp. Reaches Settlement with SEC Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 – Nutra Pharma Corporation (OTC: NPHC),…- globenewswire.com Nutra Pharma Corp. Reaches Settlement with SEC CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission…
globenewswire.com Nutra Pharma Provides Business and Compliance Updates Nutra Pharma is providing updates regarding their business plans, accounting and compliance Nutra Pharma is providing updates regarding their business plans, accounting and compliance
globenewswire.com Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against…
globenewswire.com Nutra Pharma Engages Government Affairs Consulting Firm Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental…
otcprwire.com Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of pain relief products to their marketplace Plantation,…
newsfilecorp.com Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief products to their marketplacePlantation,…
otcprwire.com Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers Plantation, Florida, June 4, 2021 – Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter…
newsfilecorp.com Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugsPlantation, Florida--(Newsfile Corp. - June 4,…
newsfilecorp.com Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief Nutra Pharma announces that professional snowboarder and wakeboarder, Jake Vedder, is endorsing Nyloxin for Chronic Pain Relief as part of their social media and influencer campaignPlantation,…
newsfilecorp.com Nutra Pharma Provides Updates on Improvements of Manufacturing Capabilities Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for the production of their over-the-counter pain relieversPlantation, Florida--(Newsfile Corp. - May…
otcprwire.com Nutra Pharma Announces Influencer and Social Media Campaign for Nyloxin and Pet Pain-Away Nutra Pharma is announcing their newest marketing plans for their over-the-counter pain relievers will utilize influencers, celebrities and athletes on social media platforms Plantation, Florida, May…
otcprwire.com Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos…
newsfilecorp.com Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and…
otcprwire.com Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical…
newsfilecorp.com Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validationPlantation, Florida--(Newsfile Corp. - February 23,…
newsfilecorp.com Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys Plantation, Florida--(Newsfile Corp. - February 12, 2021) - Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday